Hogue and colleques reported that 20% of patients who received remifentanil developed hypotension.
Hogue et al. relataron que un 20% de los pacientes que recibieron remifentanilo desarrollaron hipotensión.
Hogue et al. relataram que 20% dos pacientes que receberam remifentanil desenvolveram hipotensão.